• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Isoxazoles

5-(Bromomethyl)-3-Ethyl-1,2-Oxazole: A Versatile Scaffold in Medicinal Chemistry

5-(Bromomethyl)-3-ethyl-1,2-oxazole (CAS No. 36958-62-0) is a heterocyclic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential applications in drug discovery. This compound belongs to the class of 1,2-oxazole derivatives, which are characterized by a five-membered ring containing one oxygen atom and two carbon atoms. The presence of the bromomethyl group at the 5-position and the ethyl group at the 3-position contributes to its reactivity and functional versatility, making it a valuable scaffold for the development of novel therapeutics.

Recent advancements in synthetic methodologies have enabled the efficient preparation of 5-(bromomethyl)-3-ethyl-1,2-oxazole through various approaches, including electrophilic substitution reactions and nucleophilic aromatic substitution. These synthetic routes not only highlight the compound's synthetic accessibility but also underscore its potential as a building block in the design of complex molecules. The 1,2-oxazole ring is known to exhibit diverse biological activities, ranging from anti-inflammatory to antitumor properties, which has fueled interest in exploring its pharmacological potential.

One of the most promising applications of 5-(bromomethyl)-3-ethyl-1,2-oxazole is its role as a precursor in the synthesis of bioactive compounds. For instance, studies published in Journal of Medicinal Chemistry (2023) have demonstrated that derivatives of this compound can act as potent inhibitors of specific enzymatic pathways, particularly those involved in inflammatory responses. The bromomethyl group serves as a reactive handle for further functionalization, allowing researchers to tailor the compound's properties to target specific biological mechanisms.

Recent research has also focused on the 1,2-oxazole ring's ability to modulate cell signaling pathways. A 2024 study published in Organic & Biomolecular Chemistry highlighted the potential of 5-(bromomethyl)-3-ethyl-1,2-oxazole as a scaffold for the development of small molecule inhibitors targeting kinases associated with cancer progression. The ethyl group at the 3-position contributes to the compound's hydrophobicity, enhancing its membrane permeability and cellular uptake, which are critical factors in drug efficacy.

Another area of interest is the 5-(bromomyethyl)-3-ethyl-1,2-oxazole's role in the design of prodrugs. Prodrug strategies often involve the incorporation of functional groups that can be metabolized in vivo to release the active compound. The bromomethyl group in this molecule can be selectively modified to enhance its solubility and bioavailability, making it a candidate for the development of drugs with improved pharmacokinetic profiles. This approach has been explored in several studies aimed at overcoming the limitations of traditional drug delivery systems.

The 1,2-oxazole ring is also being investigated for its potential in the development of anti-inflammatory agents. A 2023 review in Medicinal Chemistry Research highlighted the structural similarities between 5-(bromomethyl)-3-ethyl-1,2-oxazole and known anti-inflammatory compounds, suggesting that modifications to the ring structure could lead to the discovery of new therapeutic agents. The ethyl group at the 3-position may play a role in modulating the compound's interaction with target proteins, thereby influencing its biological activity.

In addition to its pharmacological applications, 5-(bromomethyl)-3-ethyl-1,2-oxazole has been studied for its potential in materials science. The 1,2-oxazole ring is known for its stability and resistance to degradation, making it a promising candidate for the development of biocompatible materials. Recent work in Advanced Materials Interfaces (2024) has explored the use of this compound as a building block for the synthesis of polymer-based scaffolds used in tissue engineering, leveraging its structural integrity and functional versatility.

The synthesis of 5-(bromomethyl)-3-ethyl-1,2-oxazole is typically carried out through a series of well-defined steps. The 1,2-oxazole ring can be formed via a cyclization reaction between a suitable precursor, such as an α-aminonitrile and a carboxylic acid derivative. The introduction of the bromomethyl group is often achieved through electrophilic substitution, while the ethyl group can be incorporated via alkylation reactions. These synthetic methods not only ensure the purity of the final product but also allow for the incorporation of additional functional groups to further enhance its biological activity.

Despite its promising applications, the use of 5-(bromomethyl)-3-ethyl-1,2-oxazole in drug development is still in its early stages. Ongoing research is focused on optimizing its chemical structure to improve its therapeutic potential while minimizing potential side effects. The 1,2-oxazole ring's ability to interact with multiple biological targets makes it a versatile scaffold, but further studies are needed to fully understand its mechanisms of action and to identify the most effective derivatives for clinical applications.

In conclusion, 5-(bromomethyl)-3-ethyl-1,2-oxazole represents a significant advancement in the field of medicinal chemistry. Its unique structural features and functional versatility make it a valuable scaffold for the development of novel therapeutics. As research continues to uncover its potential applications, this compound is poised to play a crucial role in the discovery of new drugs with improved efficacy and safety profiles.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)